Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: J Thorac Oncol. 2012 Oct;7(10):1528–1533. doi: 10.1097/JTO.0b013e3182637d5f

Figure 1. One potential biomarker for differentiating malignant lung nodules from benign ones found by means of GC-MS.

Figure 1

1-octene shows a statistically significant difference in the peak area the benign and malignant samples (p = 0.0486). The positions of the mean values for benign and malignant states are marked with □, the boxes correspond to their 95% confidence limits, and the error bars corresponds to the standard deviation